1. Home
  2. MPLT vs TDAY Comparison

MPLT vs TDAY Comparison

Compare MPLT & TDAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

BUY

Current Price

$37.09

Market Cap

1.3B

Sector

Health Care

ML Signal

BUY

TDAY

USA TODAY Co. Inc.

N/A

Current Price

$8.83

Market Cap

1.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
MPLT
TDAY
Founded
2018
2013
Country
United States
United States
Employees
133
7500
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MPLT
TDAY
Price
$37.09
$8.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$32.67
$9.00
AVG Volume (30 Days)
437.1K
1.6M
Earning Date
05-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.06
Revenue Growth
N/A
N/A
52 Week Low
$12.24
$4.54
52 Week High
$37.61
$8.90

Technical Indicators

Market Signals
Indicator
MPLT
TDAY
Relative Strength Index (RSI) 69.84 68.49
Support Level $26.20 $6.67
Resistance Level N/A N/A
Average True Range (ATR) 2.49 0.28
MACD 0.84 0.09
Stochastic Oscillator 95.22 95.31

Price Performance

Historical Comparison
MPLT
TDAY

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About TDAY USA TODAY Co. Inc.

USA Today Co Inc is a diversified media company with national and local reach, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.

Share on Social Networks: